For: | Wan J, Zhang ZQ, You WD, Sun HK, Zhang JP, Wang YH, Fu YH. Detection of K-ras gene mutation in fecal samples from elderly large intestinal cancer patients and its diagnostic significance. World J Gastroenterol 2004; 10(5): 743-746 [PMID: 14991952 DOI: 10.3748/wjg.v10.i5.743] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i5/743.htm |
Number | Citing Articles |
1 |
Ulrike Haug, Hermann Brenner. New stool tests for colorectal cancer screening: A systematic review focusing on performance characteristics and practicalness. International Journal of Cancer 2005; 117(2): 169 doi: 10.1002/ijc.21016
|
2 |
Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri. Nicht-invasive Diagnostik kolorektaler Tumore – Hat der Guaiac-Test ausgedient? / Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?. LaboratoriumsMedizin 2008; 32(3): 158 doi: 10.1515/JLM.2008.021
|
3 |
Chih-Cheng Chien, Shu-Hung Chen, Chen-Chiung Liu, Chia-Long Lee, Ruey-Neng Yang, Shung-Haur Yang, Chi-Jung Huang. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC). Translational Research 2007; 149(2): 96 doi: 10.1016/j.trsl.2006.09.006
|
4 |
Bernard Levin. Molecular Screening Testing for Colorectal Cancer. Clinical Cancer Research 2006; 12(17): 5014 doi: 10.1158/1078-0432.CCR-06-0578
|
5 |
Rebecca S. Henkhaus, Eugene W. Gerner, Natalia A. Ignatenko. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells. bchm 2008; 389(6): 757 doi: 10.1515/BC.2008.087
|
6 |
Rong-Lin Zhai, Fei Xu, Pei Zhang, Wan-Li Zhang, Hui Wang, Ji-Liang Wang, Kai-Lin Cai, Yue-Ping Long, Xiao-Ming Lu, Kai-Xiong Tao, Guo-Bin Wang. The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer. Medicine 2016; 95(5): e2129 doi: 10.1097/MD.0000000000002129
|
7 |
Jürgen Stein, Stefan M. Loitsch, Yogesh Shastri. Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?1
. LaboratoriumsMedizin 2008; 32(3): - doi: 10.1515/JLM.2008.021et
|
8 |
Linda J.W. Bosch, Beatriz Carvalho, Remond J.A. Fijneman, Connie R. Jimenez, Herbert M. Pinedo, Manon van Engeland, Gerrit A. Meijer. Molecular Tests for Colorectal Cancer Screening. Clinical Colorectal Cancer 2011; 10(1): 8 doi: 10.3816/CCC.2011.n.002
|
9 |
Jun Wan, Hong Li, Yuan Li, Mei-Ling Zhu, Po Zhao. Loss of heterozygosity of Kras2 gene on 12p12-13 in Chinese colon carcinoma patients. World Journal of Gastroenterology 2006; 12(7): 1033-1037 doi: 10.3748/wjg.v12.i7.1033
|
10 |
Jun Wan, Hong Li, Yuan Li, Mei-Ling Zhu, Po Zhao. Loss of heterozygosity of Kras2 gene on 12p12-13 in Chinese colon carcinoma patients. World Journal of Gastroenterology 2006; 12(7): 1033-1037 doi: 10.3748/wjg.v12.i7.1033
|
11 |
Paolo Battaglia, Elisabetta Baritono, Andrea Remo, Roberto Vendraminelli, Antonio Conti. KRAS Mutations and M2PK Upregulation in Stool Samples from Individuals with Positive Fecal Occult Blood Tests Screened for Colorectal Cancer. Tumori Journal 2014; 100(2): 122 doi: 10.1177/030089161410000202
|
12 |
In-Hyuk Jung, Goo Taeg Oh. The Roles of CD137 Signaling in Atherosclerosis. Korean Circulation Journal 2016; 46(6): 753 doi: 10.4070/kcj.2016.46.6.753
|